- Home
- LPCN vs ZCMD Comparison
LPCN vs ZCMD Comparison
Compare LPCN & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- ZCMD
- Stock Information
- Founded
- LPCN 1997
- ZCMD 2012
- Country
- LPCN United States
- ZCMD China
- Employees
- LPCN N/A
- ZCMD N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- ZCMD Other Consumer Services
- Sector
- LPCN Health Care
- ZCMD Real Estate
- Exchange
- LPCN Nasdaq
- ZCMD Nasdaq
- Market Cap
- LPCN 18.2M
- ZCMD 18.3M
- IPO Year
- LPCN N/A
- ZCMD 2020
- Fundamental
- Price
- LPCN $2.60
- ZCMD $0.67
- Analyst Decision
- LPCN Strong Buy
- ZCMD
- Analyst Count
- LPCN 1
- ZCMD 0
- Target Price
- LPCN $8.00
- ZCMD N/A
- AVG Volume (30 Days)
- LPCN 59.9K
- ZCMD 794.0K
- Earning Date
- LPCN 11-07-2025
- ZCMD 01-01-0001
- Dividend Yield
- LPCN N/A
- ZCMD N/A
- EPS Growth
- LPCN N/A
- ZCMD N/A
- EPS
- LPCN N/A
- ZCMD N/A
- Revenue
- LPCN $4,208,119.00
- ZCMD $13,117,523.00
- Revenue This Year
- LPCN N/A
- ZCMD N/A
- Revenue Next Year
- LPCN N/A
- ZCMD N/A
- P/E Ratio
- LPCN N/A
- ZCMD N/A
- Revenue Growth
- LPCN N/A
- ZCMD N/A
- 52 Week Low
- LPCN $2.57
- ZCMD $0.62
- 52 Week High
- LPCN $6.17
- ZCMD $2.50
- Technical
- Relative Strength Index (RSI)
- LPCN 32.60
- ZCMD 31.27
- Support Level
- LPCN $2.75
- ZCMD $0.64
- Resistance Level
- LPCN $2.92
- ZCMD $0.83
- Average True Range (ATR)
- LPCN 0.14
- ZCMD 0.07
- MACD
- LPCN -0.05
- ZCMD -0.00
- Stochastic Oscillator
- LPCN 4.69
- ZCMD 32.45
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.